EcoDrugPlus

Ensembl ID : ENSACIG00000005464
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSACIG00000011396
Gene Symbol: TIE1
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSACIG00000008368
Gene Symbol: -
Cross references: -
146 Possible Orthologues:

Ensembl ID : ENSACIG00000011118
Gene Symbol: RPL35
1 Cross references
273 Possible Orthologues:

Ensembl ID : ENSACIG00000011059
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSACIG00000011028
Gene Symbol: -
Cross references: -
554 Possible Orthologues:

Ensembl ID : ENSACIG00000010994
Gene Symbol: -
Cross references: -
554 Possible Orthologues:

Ensembl ID : ENSACIG00000008549
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSACIG00000017241
Gene Symbol: RXRBB
1 Cross references
211 Possible Orthologues:

Ensembl ID : ENSACIG00000014710
Gene Symbol: -
Cross references: -
128 Possible Orthologues:

Ensembl ID : ENSACIG00000017423
Gene Symbol: RPLP0
1 Cross references
403 Possible Orthologues:

Ensembl ID : ENSACIG00000010241
Gene Symbol: -
Cross references: -
228 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).